Interestingly, overexpression of LINC01260 significantly inhibited the fatty change process induced by OA in LO2 cells, suggesting that LINC01260 is closely related to lipid accumulation in NAFLD cell models. Here, KCNK15-AS1 is linked to metabolic dysfunction-associated steatotic liver disease.